Whereas, gain of function mutations of LRP5 have been shown to lead to disorders of increased bone mass such as sclerostosis [19], Van Buchem's disease [20], osteopetrosis [9] and endosteal hyperostosis [10]. This evidence concerns the gene LRP5 and hyperostosis corticalis generalisata.